Articles Tagged With:
-
Cryptogenic Stroke and Atrial Fibrillation
Recent study results support monitoring patients > 60 years of age with evidence of prior stroke on brain imaging to look for atrial fibrillation.
-
Providers must tread carefully if patient objects to caregiver
Recent racial controversies have prompted some risk managers to wonder how to respond if a patient objects to the race, gender, religion, or sexual orientation of a caregiver.
-
Alirocumab Injection (Praluent)
Alirocumab provides a new mechanism of action for lowering cholesterol in patients who have not achieved adequate lowering on maximum dose of statins.
-
Study suggests more training, support for nurses treating patients with behavioral health concerns
Caring for patients with behavioral health concerns presents a number of challenges in the emergency setting.
-
New CM model strives for more efficient transitions
An efficient transition of care system can provide faster transitions from acute care facilities to skilled nursing facilities.
-
Having states pass the revised Nurse Licensure Compact could help CMs
A new Nurse Licensure Compact would allow registered nurses or licensed practical/vocational nurses to possess a multistate license that permits them to practice in their home states and other NLC states.
-
Migraine and Cognitive Dysfunction
During an attack of migraine without aura, patients may experience transient cognitive impairment, with predominant involvement of verbal processing speed, learning, and memory, due to reversible cortical dysfunction.
-
Here are some tips on helping CMs evolve into policy leaders
Case managers just need a little confidence and a big mission to become public policy leaders, experts say.
-
Case managers are a natural fit for roles in public policy advocacy
Professional case managers make natural public policy advocates because of their broad knowledge of healthcare and their leadership experience.
-
Is Low Testosterone Therapy Worth the Hype in the Elderly?
Testosterone replacement therapy showed no impact on subclinical atherosclerosis progression in recent study.